| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.37 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.34 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |